Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Adrenergic Beta-Antagonists and Glycerol

Research Papers that Mention the Interaction

The rise in plasma free fatty acids and glycerol during exercise was also significantly attenuated by both beta blockers in comparison with the rise in those taking placebo (P < 0.01).
British journal of sports medicine  •  1997  |  View Paper
Free fatty acids and glycerol were similarly reduced by both beta-blocking agents.
Zeitschrift fur Kardiologie  •  1984  |  View Paper
beta-blockade reduced the increases of lactate, glucose, glycerol , insulin, and growth hormone, exaggerated the depression of FFA and had no effect on cortisol.
European journal of applied physiology and occupational physiology  •  1984  |  View Paper
The increase of glycerol , free fatty acids and ketone bodies was markedly reduced after pretreatment with the beta blocker compared with the controlgroup.
Der Anaesthesist  •  1978  |  View Paper
In all patients given beta-blockade , Ra glycerol decreased greatly.
Annals of surgery  •  1987  |  View Paper
Losartan, an Ang II receptor 1 blocker, and carvedilol, an alpha1-nonselective-beta1,2,3-adrenergic blocker, but not doxazosin, an alpha1-selective-adrenergic blocker , lowered glycerol and norepinephrine levels, preventing lipolysis and weight loss.
The Journal of clinical endocrinology and metabolism  •  2005  |  View Paper
Incorporation of [3H]glycerol into disaturated phosphatidylcholine was augmented by beta-adrenergic agents but was not significantly different from the enhanced incorporation rate when colchicine was present.
Journal of applied physiology  •  1985  |  View Paper
Increasing beta-blocker concentrations (0-10 mM for acebutolol and oxprenolol, and 0-1.5 mM for propranolol) significantly rigidifies the lipid bilayer at the glycerol and headgroup level, which was detected in the steady-state and in the time-resolved fluorescence data.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V  •  2014  |  View Paper